期刊文献+

血管内皮生长因子可溶性受体flt-1_(n3)对裸鼠人膀胱癌生长的影响 被引量:3

The soluble receptor flt-1_(n3) of vascular endothelial growth factor inhibits bladder carcinoma angiogenesis and growth
原文传递
导出
摘要 目的 研究血管内皮生长因子 (VEGF)受体flt 1胞外区基因抗肿瘤新生血管生成的作用。 方法 采用脂质体转染技术将含有flt 1胞外区前三个IgG样结构区域的真核表达质粒 pcD NA3.1/KDRn7转入人膀胱癌EJ细胞 ,用G418筛选得到稳定表达目的蛋白的细胞克隆 ,经固相结合实验筛选得到表达与VEGF特异结合的目的蛋白的细胞克隆 ,阳性细胞克隆进行PCR和RT PCR鉴定。对裸鼠人膀胱癌组织切片进行免疫组化染色 ,定量分析微血管密度。 结果 PCR和RT PCR结果显示重组质粒转入EJ细胞及在转录水平表达 ;免疫组化的微血管密度实验组明显低于阴性对照组。 结论 阻断VEGF/flt 1信号传导途径能够抑制肿瘤新生血管的形成 。 Objective To verify whether the extracellular domain of flt 1 has anti angionesis activity in vivo. Methods A recombinant plasmid pcDNA 3.1/flt 1 n3 was transfected into the human bladder carcinoma EJ cell by lipofectamin, which was constructed by inserting the N terminal first three IgG like domain of VEGF receptor flt 1 (flt 1 n3 ) into eukaryotic expression vector pcDNA 3.1. Results The rflt 1 was functionally expressed in stably transfected EJ and the product secreted in the medium could be specifically bind to rhVEGF165.The result showed that the bladder cancer transfected with rflt 1 had a lower microvessle density than the control. Conclusions It is proved that the expressed rflt 1 n3 can inhibit tumor growth and angiogenesis in nude mice model.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2001年第8期460-463,共4页 Chinese Journal of Urology
基金 国家 8 63高技术规划基金资助 (10 2 0 8 0 1 0 3 )
关键词 膀胱肿瘤 血管内皮生长因子受体 动物实验 Bladder neoplasms Carcinoma VEGF receptor
  • 相关文献

参考文献8

二级参考文献4

共引文献10

同被引文献27

  • 1张南生,董光同,孙卫军,张秀华,刘存丽.参一胶囊对肺癌患者血清血管内皮细胞生长因子的影响[J].温州医学院学报,2006,36(3):273-274. 被引量:14
  • 2Matsumura M, Chiba Y, Lu C, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer.Cancer Lett, 1998,128:55-63.
  • 3Arima J, Imazono Y, Takebayashi Y, et al. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder. Cancer,2000,88 : 1131-1138.
  • 4Li S, Nomata K, Sawase K, et al. Prognostic significance of plateletderived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer. Int J Urol,2001,8:478-482.
  • 5OBrien T, Cranston D, Fuggle S, et al. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res,1995,55:510-513.
  • 6Jager TM, Weidner N, Chew K, et al. Tumor angiogenesis correlates with lymph node metastasis in invasive bladder cancer. J Urol, 1995,154:69-71.
  • 7Hawke CK, Delahunt B, Davidson PJT. Microvessel density as a prognostic marker for transitional cell carcinoma of the bladder. Br J Urol, 1998:585-590.
  • 8Miyadera K, Sumtzawa T, Haraguchi M, et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res,1995,55:1687-1690.
  • 9Oltryne K J, Koukourakis M J, Giatromanolaki A, et al. Vascular endothelial growth factor, platelet derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer, 2000,82:1427-1432.
  • 10Larry Witte,Daniel J. Hicklin,Zhenping Zhu,Bronislaw Pytowski,Helen Kotanides,Patricia Rockwell,Peter B?hlen.Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy[J]. Cancer and Metastasis Reviews . 1998 (2)

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部